Sanofi (SNYNF)
SNYNF Stock Price Chart
Explore Sanofi interactive price chart. Choose custom timeframes to analyze SNYNF price movements and trends.
SNYNF Company Profile
Discover essential business fundamentals and corporate details for Sanofi (SNYNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
9 Apr 2008
Employees
82.88K
Website
https://www.sanofi.comCEO
Paul Hudson
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
SNYNF Financial Timeline
Browse a chronological timeline of Sanofi corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 28 Jan 2026
Upcoming earnings on 24 Oct 2025
Revenue estimate is $12.61B.
Earnings released on 31 Jul 2025
EPS came in at $3.76 , while revenue for the quarter reached $12.64B , beating expectations by +2.28%.
Earnings released on 24 Apr 2025
EPS came in at $1.79 surpassing the estimated $1.69 by +5.92%, while revenue for the quarter reached $11.63B , beating expectations by +16.31%.
Earnings released on 30 Jan 2025
EPS came in at $1.31 falling short of the estimated $1.69 by -22.49%, while revenue for the quarter reached $7.90B , missing expectations by -16.89%.
Dividend declared on 30 Jan 2025
A dividend of $4.38 per share was announced, adjusted to $4.41. The dividend was paid on 14 May 2025.
Earnings released on 25 Oct 2024
EPS came in at $2.86 surpassing the estimated $2.48 by +15.32%, while revenue for the quarter reached $15.53B , beating expectations by +11.76%.
Earnings released on 25 Jul 2024
EPS came in at $1.73 surpassing the estimated $1.67 by +3.59%, while revenue for the quarter reached $22.80B , beating expectations by +78.59%.
Earnings released on 25 Apr 2024
EPS came in at $1.78 surpassing the estimated $1.73 by +2.89%, while revenue for the quarter reached $11.94B .
Earnings released on 1 Feb 2024
EPS came in at $1.66 falling short of the estimated $1.68 by -1.19%, while revenue for the quarter reached $25.17B .
Dividend declared on 1 Feb 2024
A dividend of $4.06 per share was announced, adjusted to $4.05. The dividend was paid on 15 May 2024.
Earnings released on 27 Oct 2023
EPS came in at $2.55 falling short of the estimated $2.61 by -2.30%, while revenue for the quarter reached $13.39B .
Earnings released on 28 Jul 2023
EPS came in at $1.74 surpassing the estimated $1.63 by +6.75%, while revenue for the quarter reached $11.65B .
Earnings released on 27 Apr 2023
EPS came in at $2.16 surpassing the estimated $2.01 by +7.46%, while revenue for the quarter reached $11.81B .
Earnings released on 3 Feb 2023
EPS came in at $1.71 matching the estimated $1.71, while revenue for the quarter reached $12.34B .
Dividend declared on 3 Feb 2023
A dividend of $3.82 per share was announced, adjusted to $3.81. The dividend was paid on 1 Jun 2023.
Earnings released on 28 Oct 2022
EPS came in at $2.87 surpassing the estimated $2.70 by +6.30%, while revenue for the quarter reached $12.83B , beating expectations by +9.11%.
Earnings released on 28 Jul 2022
EPS came in at $1.73 surpassing the estimated $1.64 by +5.49%, while revenue for the quarter reached $11.24B , missing expectations by -4.44%.
Stock split effective on 6 May 2022
Shares were split 1005 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Apr 2022
EPS came in at $1.94 surpassing the estimated $1.78 by +8.99%, while revenue for the quarter reached $11.12B , missing expectations by -5.44%.
Earnings released on 4 Feb 2022
EPS came in at $1.38 surpassing the estimated $1.33 by +3.76%, while revenue for the quarter reached $11.81B , beating expectations by +0.41%.
Dividend declared on 4 Feb 2022
A dividend of $3.52 per share was announced, adjusted to $3.49. The dividend was paid on 10 May 2022.
Earnings released on 28 Oct 2021
EPS came in at $2.18 surpassing the estimated $2.00 by +9.00%, while revenue for the quarter reached $12.57B , beating expectations by +5.34%.
Earnings released on 29 Jul 2021
EPS came in at $1.38 surpassing the estimated $1.32 by +4.55%, while revenue for the quarter reached $10.73B .
Earnings released on 28 Apr 2021
EPS came in at $1.61 surpassing the estimated $1.42 by +13.38%, while revenue for the quarter reached $10.45B .
Earnings released on 5 Feb 2021
EPS came in at $1.22 surpassing the estimated $1.19 by +2.52%, while revenue for the quarter reached $11.94B .
Dividend declared on 5 Feb 2021
A dividend of $3.84 per share was announced, adjusted to $3.82. The dividend was paid on 7 May 2021.
Earnings released on 29 Oct 2020
EPS came in at $1.83 surpassing the estimated $1.81 by +1.10%, while revenue for the quarter reached $11.60B .
SNYNF Stock Performance
Access detailed SNYNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.